Two Sigma Investments’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,771
| Closed | -$135K | – | 3466 |
|
|
2025
Q1 | $135K | Sell |
10,771
-87,307
| -89% | -$1.1M | ﹤0.01% | 2859 |
|
|
2024
Q4 | $1.03M | Sell |
98,078
-115,987
| -54% | -$1.22M | ﹤0.01% | 2096 |
|
|
2024
Q3 | $3.1M | Buy |
214,065
+167,141
| +356% | +$2.42M | 0.01% | 1320 |
|
|
2024
Q2 | $399K | Buy |
46,924
+26,507
| +130% | +$226K | ﹤0.01% | 2396 |
|
|
2024
Q1 | $209K | Sell |
20,417
-41,308
| -67% | -$422K | ﹤0.01% | 2625 |
|
|
2023
Q4 | $338K | Buy |
61,725
+8,878
| +17% | +$48.7K | ﹤0.01% | 2564 |
|
|
2023
Q3 | $200K | Sell |
52,847
-538,935
| -91% | -$2.04M | ﹤0.01% | 2566 |
|
|
2023
Q2 | $3.96M | Buy |
591,782
+479,801
| +428% | +$3.21M | 0.01% | 973 |
|
|
2023
Q1 | $729K | Buy |
111,981
+10,835
| +11% | +$70.5K | ﹤0.01% | 1964 |
|
|
2022
Q4 | $863K | Sell |
101,146
-15,654
| -13% | -$134K | ﹤0.01% | 1717 |
|
|
2022
Q3 | $617K | Sell |
116,800
-76,700
| -40% | -$405K | ﹤0.01% | 1634 |
|
|
2022
Q2 | $820K | Sell |
193,500
-207,676
| -52% | -$880K | ﹤0.01% | 1571 |
|
|
2022
Q1 | $1.41M | Buy |
401,176
+9,492
| +2% | +$33.3K | ﹤0.01% | 1485 |
|
|
2021
Q4 | $2.61M | Buy |
391,684
+241,112
| +160% | +$1.61M | 0.01% | 1203 |
|
|
2021
Q3 | $1.5M | Buy |
+150,572
| New | +$1.5M | ﹤0.01% | 1503 |
|